Commission Implementing Regulation (EU) 2023/1764 of 12 September 2023 granting a Union authorisation for the biocidal product family ‘Oxy’Pharm H2O2’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)

A Union authorisation with authorisation number EU-0029752-0000 is granted to OXY’PHARM for the making available on the market and use of the biocidal product family ‘Oxy’Pharm H2O2’ in accordance with the summary of the biocidal product characteristics set out in the Annex. The Union authorisation is valid from 3 October 2023 until 30 September 2033.

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.